scholarly journals ANTEGRADE URETERIC STENTING IN MANAGEMENT OF URETERIC OBSTRUCTION IN CASE OF DIFFICULT RETROGRADE ACCESS; INDICATIONS, SUCCESS RATES & PREDICTORS OF FAILURE

2021 ◽  
Vol 72 (3) ◽  
pp. 465-477
Author(s):  
Khaled Taema ◽  
Hany Gad ◽  
Mohamed Ahmed ◽  
Amr Zriek
Keyword(s):  
Ureteric Obstruction ◽  
Success Rates ◽  
Ureteric Stenting

scholarly journals Management of an inflammatory abdominal aortic aneurysm causing ureteric obstruction: a case report

2020 ◽  
Vol 2020 (11) ◽  
Author(s):  
Yewon Kim ◽  
Paul Ghaly ◽  
Jim Iliopoulos ◽  
Gregory J Leslie ◽  
Mehtab Ahmad
Keyword(s):  
Aortic Aneurysm ◽  
Aortic Rupture ◽  
Obstructive Uropathy ◽  
Aortic Aneurysms ◽  
Ureteric Obstruction ◽  
Ureteric Stenting ◽  
Abdominal Aortic ◽  
Life Threatening ◽  
Aneurysm Repair ◽  
Inflammatory Abdominal Aortic Aneurysm

Abstract Inflammatory abdominal aortic aneurysms (IAAAs) are rare large-vessel pathology, with potentially life-threatening complications including obstructive uropathy secondary to retroperitoneal fibrosis. Comprising a small proportion of all AAA, their pathogenesis remains unknown, with the hypothesis of infective and immunological aetiologies circulating in current literature. Management principles of IAAAs aim at prevention of aortic rupture and include open-surgical or endovascular therapies. Due to their involvement of other structures, additional considerations are needed when approaching their management for optimal patient outcomes. We present the case of a 53-year-old otherwise healthy male with a large IAAA complicated by adjacent ureteric obstruction, successfully treated with ureteric stenting and delayed endovascular aortic aneurysm repair.

scholarly journals Outcome of retrograde ureteric stenting as a urinary drainage procedure in ureteric obstruction related to malignant lesions

2014 ◽  
Vol 59 (4) ◽  
pp. 124 ◽  
Author(s):  
S Wijayarathna ◽  
S Suvendran ◽  
M Ishak ◽  
A Weligamage ◽  
A Epa ◽  
...  
Keyword(s):  
Ureteric Obstruction ◽  
Drainage Procedure ◽  
Ureteric Stenting ◽  
Urinary Drainage ◽  
Malignant Lesions

The value of ureteric stenting in the management of malignant ureteric obstruction

2003 ◽  
Vol 2 (1) ◽  
pp. 200
Author(s):  
M. Hussain ◽  
F. Pakzad ◽  
C.R.J. Woodhouse ◽  
A.C. Thompson
Keyword(s):  
Ureteric Obstruction ◽  
Ureteric Stenting

Voice Therapy With Seniors: Attendance, Outcomes, and Associated Patient Characteristics

2019 ◽  
Vol 4 (5) ◽  
pp. 814-824 ◽  
Author(s):  
Bonnie E. Smith ◽  
Ruth Huntley Bahr ◽  
Hector N. Hernandez
Keyword(s):  
Outcome Data ◽  
Voice Therapy ◽  
Similar Data ◽  
Success Rates ◽  
Reflux Symptom Index ◽  
Voice Change ◽  
Related Factors ◽  
Symptom Index ◽  
Younger Patients ◽  
Unsuccessful Treatment

Purpose The purpose of this study was to determine the attendance and success rates for seniors in voice therapy, identify any contributing patient-related factors, and compare results to existing findings for younger patients. Method This retrospective study included information from the voice records of 50 seniors seen by the same speech-language pathologist in a private practice. Analysis of attendance and outcome data divided participants into 6 groups. Outcomes for Groups 1–3 (64% of patients) were considered successful (positive voice change), while outcomes for Groups 4–6 (36% of patients) were considered unsuccessful. These data were compared to similar data collected for younger adults in a previous study. Results The attendance and success rates for seniors in this study were higher than those previously reported for younger patients. Further consideration of patient factors revealed that reports of increased stress, Reflux Symptom Index scores > 13, and higher Voice Handicap Index functional subscale scores were significant in distinguishing between patients in the successful and unsuccessful treatment outcome groups. Conclusions The relatively high attendance and success rates among this sample of seniors suggest the desire to achieve voice improvement does not diminish with age, and chances for success in voice therapy among nonfrail seniors may be greater than for younger patients.

1548: Racial Disparities in Kidney-Transplant Graft Outcomes, with a Proposal to Improve Graft Success Rates

2005 ◽  
Vol 173 (4S) ◽  
pp. 419-419
Author(s):  
Constance Marks ◽  
Carlumandarlo E.B. Zaramo ◽  
Joan M. Alster ◽  
Charles Modlin
Keyword(s):  
Racial Disparities ◽  
Kidney Transplant ◽  
Success Rates ◽  
Graft Success

Strict IVF Restrictions Could Lower Success Rates

2006 ◽  
Vol 36 (24) ◽  
pp. 40
Author(s):  
KATE JOHNSON
Keyword(s):  
Success Rates

ITI with high-dose FIX and combined immunosuppressive therapy in a patient with severe haemophilia B and inhibitor

2009 ◽  
Vol 29 (02) ◽  
pp. 155-157 ◽  
Author(s):  
H. Hauch ◽  
J. Rischewski ◽  
U. Kordes ◽  
J. Schneppenheim ◽  
R. Schneppenheim ◽  
...  
Keyword(s):  
Nephrotic Syndrome ◽  
Immunosuppressive Agents ◽  
Tolerance Induction ◽  
Intravenous Immunoglobulins ◽  
Factor Ix ◽  
High Dose ◽  
Allergic Reactions ◽  
Success Rates ◽  
Serious Infections ◽  
History Of

SummaryInhibitor development is a rare but serious event in hemophilia B patients. Management is hampered by the frequent occurrence of allergic reactions to factor IX, low success rates of current inhibitor elimination protocols and the risk of development of nephrotic syndrome. Single cases of immune tolerance induction (ITI) including immunosuppressive agents like mycophenolat mofetil (MMF) or rituximab have been reported. We present a case of successful inhibitor elimination with a combined immune-modulating therapy and high-dose factor IX (FIX). This boy had developed a FIX inhibitor at the age of 5 years and had a history of allergic reactions to FIX and to FEIBA→. Under on-demand treatment with recombinant activated FVII the inhibitor became undetectable but the boy suffered from multiple joint and muscle bleeds. At the age of 11.5 years ITI was attempted with a combination of rituximab, MMF, dexamethasone, intravenous immunoglobulins and high-dose FIX. The inhibitor did not reappear and FIX half-life normalized. No allergic reaction, no signs of nephrotic syndrome and no serious infections were observed.

Sign in / Sign up

Export Citation Format

Share Document